The Valley Desk

NCT00122304 · Interventional trial

Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab

Overall registry status Completed

Phase 3

Conditions Hemoglobinuria, Paroxysmal

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov